Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach-Reference-Cited by-同舟云学术

Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach

Published:2023-08-10 Issue:3 Volume:14 Page:477-502
ISSN:1878-5085
Container-title:EPMA Journal
language:en
Short-container-title:EPMA Journal

Author:

Zhang Yuping,Li Na,Yang Lamei,Jia Wenshuang,Li Zhijun,Shao Qianwen,Zhan Xianquan^ORCID

Funder

the Shandong Provincial Taishan Scholar Engineering Project Special Funds

SCIBP Supported Projects

the Shandong Provincial Natural Science Foundation

he Shandong First Medical University Talent Introduction Funds

the Shandong First Medical University High-level Scientific Research Achievement Cultivation Funding Program

China National Nature Scientific Funds

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Health Policy,Drug Discovery

Link

https://link.springer.com/content/pdf/10.1007/s13167-023-00335-3.pdf

Reference75 articles.

1. Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020;1873:188314. https://doi.org/10.1016/j.bbcan.2019.188314.

2. Rimassa L, Finn RS, Sangro B. Combination immunotherapy for hepatocellular carcinoma. J Hepatol. 2023. https://doi.org/10.1016/j.jhep.2023.03.003.

3. Lebossé F, Zoulim F. Hepatitis B vaccine and liver cancer. Bull Cancer. 2021;108:90–101. https://doi.org/10.1016/j.bulcan.2020.10.014.

4. Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18:293–313. https://doi.org/10.1038/s41575-020-00395-0.

5. Faivre S, Rimassa L, Finn RS. Molecular therapies for HCC: looking outside the box. J Hepatol. 2020;72:342–52. https://doi.org/10.1016/j.jhep.2019.09.010.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FHOD3 shows clinical significance in progression of ovarian cancer through regulation of caspase-3 signaling pathway;Gene;2024-09